SavedAdd your journal

Journals / Türk Nefroloji Diyaliz ve Transplantasyon Dergisi / 2011 / Cilt: 20 - Sayı: 2

The frequency of metabolic syndrome in patients on continuous ambulatory peritoneal dialysis and the association of developing metabolic syndrome wıth dialysis duration

Sürekli ayaktan periton diyalizi hastalarında metabolik sendrom sıklığı ve metabolik sendrom gelişiminin diyaliz süresi ile ilişkisi

Hasan KAYABAŞI
YILDIRIM Yaşar
Zülfükar YILMAZ
İdris YILDIRIM
M. Emin YILMAZ
Ali Kemal KADİROĞLU
Pages
168–172
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There was a statistically significant difference between patients with and without MS regarding age, BMI, waist circumference, PD duration, and triglyceride levels (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVE: To evaluate the characteristics of patients with metabolic syndrome, and the association of developing MS with peritoneal dialysis duration among patients undergoing continuous ambulatory peritoneal dialysis.MATERIAL and METHODS: Fifty-eight nondiabetic CAPD patients were evaluated.
📊
Key Findings & Data:The patients were divided into 3 groups according to dialysis duration (Group 1: ≤60 months, Group 2: 61-120 months, Group 3: ≥121 months) and the frequency of MS was compared.RESULTS: Twenty-four of 58 patients were male, and MS was present in 22 (37.9%) patients. 14 (82.4%) of 22 patients with MS were female, (p=0.544).
💡
Conclusion & Impact:There was a statistically significant difference between patients with and without MS regarding age, BMI, waist circumference, PD duration, and triglyceride levels (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

OBJECTIVE: To evaluate the characteristics of patients with metabolic syndrome, and the association of developing MS with peritoneal dialysis duration among patients undergoing continuous ambulatory peritoneal dialysis.MATERIAL and METHODS: Fifty-eight nondiabetic CAPD patients were evaluated. Biochemical parameters, blood pressure, length, weight, waist circumference, and body mass indexes were recorded. MS was determined using NCP-ATP III criteria. The patients were divided into 3 groups according to dialysis duration (Group 1: ≤60 months, Group 2: 61-120 months, Group 3: ≥121 months) and the frequency of MS was compared.RESULTS: Twenty-four of 58 patients were male, and MS was present in 22 (37.9%) patients. 14 (82.4%) of 22 patients with MS were female, (p=0.544). There was a statistically significant difference between patients with and without MS regarding age, BMI, waist circumference, PD duration, and triglyceride levels (p

Özet

AMAÇ: Sürekli ayaktan periton diyaliz (SAPD) tedavisi gören hastalarımızda metabolik sendromlu (MS) hastaların özelliklerini ve MS gelişimi ile SAPD süresi arasındaki ilişkiyi araştırmayı amaçladık.GEREÇ ve YÖNTEMLER: En az 1 yıldır SAPD tedavisi alan 58 nondiyabetik hasta incelendi. Tüm hastaların biyokimyasal göstergeleri, kan basınçları, boy, kilo, bel çevreleri ve vücut kütle indeksleri kaydedildi. MS, Ulusal Kolesterol Eğitim Programı (Adult Treatment Panel III) ölçütlerine göre tanımlandı. Hastalar PD sürelerine göre 3 gruba ayrıldı (Grup 1: ≤ 60 ay, Grup 2: 61-120 ay ve Grup 3: ≥ 121 ay) ve MS gelişim sıklığı karşılaştırıldı.BULGULAR: 58 hastanın 24'ü erkek, 34'ü kadındı. Hastaların 22 (%37,9)'sinde MS saptanırken, 36 (%62,1)'sında saptanmadı. MS saptanan 22 hastanın 14'ü (%82,4) kadın, 8'i (%17,6) erkeklerden oluşmakta idi (p=0,544). MS olan grupla olmayan grup karşılaştırıldığında yaş, VKİ, bel çevresi, PD süresi ve trigliserid düzeyleri arasında fark saptanırken (p

🔖

Cite This Article

KAYABAŞI, H., Yaşar, Y., YILMAZ, Z., YILDIRIM, İ., YILMAZ, M. E., KADİROĞLU, A. K. (2022). The frequency of metabolic syndrome in patients on continuous ambulatory peritoneal dialysis and the association of developing metabolic syndrome wıth dialysis duration. Türk Nefroloji Diyaliz ve Transplantasyon Dergisi, Cilt: 20 - Sayı: 2, 168–172. https://ajindex.com/articles/636460

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Sitter T, Sauter M: Impact of glucose in peritoneal dialysis: Saint or sinner. Perit Dial Int 2005
  2. 425 2. Holmes CJ, Shockley TR: Strategies to reduce glucose exposure in peritoneal dialysis patients. Perit Dial Int 2000
  3. 41 3. Heimbürger O, Waniewski J, Werynski A, Lindholm B: A quantitative description of solute and fluid transport during peritoneal dialysis. Kidney Int 1992
  4. 1332 4. Bergström J, Fürst P, Alvestrand A, Lindholm B: Protein and energy intake, nitrogen balance and nitrogen losses in patients treated with continuous ambulatory peritoneal dialysis. Kidney Int 1993
  5. 1057 5. Grostein GP, Blumenkrantz MJ, Kopple JD, Moran JK, Coburn JW: Glucose absorption during continuous ambulatory peritoneal dialysis. Kidney Int 1981
  6. 567 6. Holmes C, Mujais S: Glucose sparing in peritoneal dialysis: Implications and metrics. Kidney Int 2006
  7. 109 7. Luke RG: Chronic renal failure-a vasculopathic state. N Engl J Med 1998
  8. 843 8. Locatelli F, Marcelli D, Conte F, D’Amico M, Del Vecchio L, Limido A, Malberti F, Spotti D: Cardiovascular disease in chronic renal failure: The challenge continues. Nephrol Dial Transplant 2000
  9. 80 9. Levey AS, Beto JA, Coronado BE, Eknoyan G, Foley RN, Kasiske BL, Klag MJ, Mailloux LU, Manske CL, Meyer KB, Parfrey PS, Pfeffer MA, Wenger NK, Wilson PWF, Wright JT Jr: Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here? Am J Kidney Dis 1998
  10. 906 10. Brunner FP, Selwood NH: Profile of patients on RRT in Europe and death rates due to major causes of death groups. The EDTA Registration Committee. Kidney Int Suppl 1992
  11. 15 11. Serdengeçti K, Süleymanlar G, Altıparmak MR, Seyahi N, TND Registry Grubu: Türk Nefroloji Derneği Kayıt Sistemi Raporları-2009 12. Park SH, Lindholm B: Definition of metabolic syndrome in peritoneal dialysis. Perit Dial Int 2009
  12. 144 13. Johnson DW, Armstrong K, Campbell SB, Mudge DW, Hawley CM, Coombes JS, Prins JB, Isbel NM: Metabolic syndrome in severe chronic kidney disease: Prevalence, predictors, prognostic significance and effects of risk factor modification. Nephrology (Carlton) 2007
  13. 398 14. Laaksonen DE, Lakka HM, Niskanen LK, Kaplan GA, Salonen JT, Lakka TA: Metabolic syndrome and development of diabetes mellitus: Application and validation of recently suggested definitions of the metabolic syndrome in a prospective c